WALTHAM, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the company approved the grant of equity awards to three new employees with a ...

The treatment of thrombosis as well as the prevention of recurrent thrombosis in APS has been focused on utilizing antithrombotic medications. Recurrences, in spite of treatment, have been ...

The HELLP syndrome may be complete or incomplete. In the Tennessee Classification System diagnostic criteria for HELLP are haemolysis with increased LDH (> 600 U/L), AST (≥ 70 U/L), and ...

As of 12:45:48 PM EST. Market Open.